Analyzing Clinical Trial Experiences of Prostate Cancer Patients

Starting soon

Conditions studied: Prostate Cancer

In brief

Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the participation or completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Prostate Cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might shed insights for the sake of future Prostate Cancer patients.

Key facts

Study ID

NCT05411354

Run by

Power Life Sciences Inc.

People needed

400

Starts

2024-09-01

Expected to finish

2026-09-01

Last updated by the study team

2024-01-02

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patient has been diagnosed with Prostate Cancer as identified by imaging
• Patient has self-identified as planning to enroll in an interventional clinical trial for Prostate Cancer
• Patient is at least 18 years of age

You may not qualify if…

• Patient does not understand, sign, and return consent form
• Inability to perform regular electronic reporting
• Patient has a ECOG score of 4

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.